Kelleher C - Search Results

1

Developments in the management of autosomal dominant polycystic kidney disease.

Masoumi A, Reed-Gitomer B, Kelleher C, Bekheirnia MR, Schrier RW. Masoumi A, et al. Among authors: kelleher c. Ther Clin Risk Manag. 2008 Apr;4(2):393-407. doi: 10.2147/tcrm.s1617. Ther Clin Risk Manag. 2008. PMID: 18728845 Free PMC article.

2

Potential pharmacological interventions in polycystic kidney disease.

Masoumi A, Reed-Gitomer B, Kelleher C, Schrier RW. Masoumi A, et al. Among authors: kelleher c. Drugs. 2007;67(17):2495-510. doi: 10.2165/00003495-200767170-00004. Drugs. 2007. PMID: 18034588 Review.

3

Characteristics of hypertension in young adults with autosomal dominant polycystic kidney disease compared with the general U.S. population.

Kelleher CL, McFann KK, Johnson AM, Schrier RW. Kelleher CL, et al. Am J Hypertens. 2004 Nov;17(11 Pt 1):1029-34. doi: 10.1016/j.amjhyper.2004.06.020. Am J Hypertens. 2004. PMID: 15533729

4

Variation in age at ESRD in autosomal dominant polycystic kidney disease.

Reed BY, McFann K, Bekheirnia MR, Nobakhthaghighi N, Masoumi A, Johnson AM, Shamshirsaz AA, Kelleher CL, Schrier RW. Reed BY, et al. Am J Kidney Dis. 2008 Feb;51(2):173-83. doi: 10.1053/j.ajkd.2007.10.037. Am J Kidney Dis. 2008. PMID: 18215695 Free PMC article.

5

Presence of de novo mutations in autosomal dominant polycystic kidney disease patients without family history.

Reed B, McFann K, Kimberling WJ, Pei Y, Gabow PA, Christopher K, Petersen E, Kelleher C, Fain PR, Johnson A, Schrier RW. Reed B, et al. Among authors: kelleher c. Am J Kidney Dis. 2008 Dec;52(6):1042-50. doi: 10.1053/j.ajkd.2008.05.015. Epub 2008 Jul 21. Am J Kidney Dis. 2008. PMID: 18640754 Free PMC article.

6

Novel Complement Therapeutics in Development as Potential Treatment for Renal Disease.

Kelleher C, Kocinsky H. Kelleher C, et al. Adv Chronic Kidney Dis. 2020 Mar;27(2):95-103. doi: 10.1053/j.ackd.2020.02.006. Adv Chronic Kidney Dis. 2020. PMID: 32553251 Review.

7

Hypertension in older adults.

Kelleher C. Kelleher C. Adv Ren Replace Ther. 2000 Jan;7(1):22-31. doi: 10.1016/s1073-4449(00)70003-3. Adv Ren Replace Ther. 2000. PMID: 10672915 Review.

8

CLCN5 mutation Ser244Leu is associated with X-linked renal failure without X-linked recessive hypophosphatemic rickets.

Kelleher CL, Buckalew VM, Frederickson ED, Rhodes DJ, Conner DA, Seidman JG, Seidman CE. Kelleher CL, et al. Kidney Int. 1998 Jan;53(1):31-7. doi: 10.1046/j.1523-1755.1998.00752.x. Kidney Int. 1998. PMID: 9452997 Free article.

9

Urinary megalin deficiency implicates abnormal tubular endocytic function in Fanconi syndrome.

Norden AGW, Lapsley M, Igarashi T, Kelleher CL, Lee PJ, Matsuyama T, Scheinman SJ, Shiraga H, Sundin DP, Thakker RV, Unwin RJ, Verroust P, Moestrup SK. Norden AGW, et al. J Am Soc Nephrol. 2002 Jan;13(1):125-133. doi: 10.1681/ASN.V131125. J Am Soc Nephrol. 2002. PMID: 11752029

10

Sociodemographic factor associations with maternal and placental outcomes: A cluster and partial least squares regression analysis.

Teo SM, Segurado R, Mehegan J, Douglass A, Murrin CM, Cronin M, Kelleher CC, McAuliffe FM, Phillips CM. Teo SM, et al. Among authors: kelleher cc. Placenta. 2024 May;150:62-71. doi: 10.1016/j.placenta.2024.04.001. Epub 2024 Apr 7. Placenta. 2024. PMID: 38593637 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

522 results

Search Page